Free Trial

Nurix Therapeutics (NRIX) Institutional Ownership

Nurix Therapeutics logo
$16.00 -0.18 (-1.11%)
Closing price 04:00 PM Eastern
Extended Trading
$15.95 -0.05 (-0.31%)
As of 04:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Nurix Therapeutics (NASDAQ:NRIX)

Number of
Institutional Buyers
(last 12 months)
121
Total
Institutional Inflows
(last 12 months)
$682.65M
Number of
Institutional Sellers
(last 12 months)
58
Total
Institutional Outflows
(last 12 months)
$174.14M
Get NRIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nurix Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

NRIX Institutional Buying and Selling by Quarter

Nurix Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Sei Investments Co.82,108$1.27M0.0%+128.2%0.079%
5/8/2026 Amova Asset Management Americas Inc.1,181,146$18.28M0.3%-8.5%1.142%
5/7/2026 Dimensional Fund Advisors LP780,696$12.09M0.0%+81.1%0.755%
5/7/2026 AlphaCentric Advisors LLC25,571$396K0.4%+41.0%0.025%
5/7/2026 KBC Group NV2,192$34K0.0%N/A0.002%
5/6/2026 Allspring Global Investments Holdings LLC13,410$208K0.0%N/A0.013%
5/5/2026 Bank of New York Mellon Corp295,345$4.58M0.0%+2.5%0.286%
4/30/2026 Sumitomo Mitsui Trust Group Inc.1,181,146$18.31M0.0%-8.5%1.142%
4/27/2026 Y Intercept Hong Kong Ltd55,138$855K0.0%N/A0.053%
4/22/2026 Pictet Asset Management Holding SA2,726,138$42.26M0.0%-21.4%2.636%
4/22/2026 Sterling Capital Management LLC3,376$52K0.0%-41.6%0.003%
4/16/2026 SG Americas Securities LLC18,974$294K0.0%-38.7%0.018%
3/9/2026Flax Pond Capital LLC80,200$1.52M1.1%N/A0.078%
3/3/2026 Caitong International Asset Management Co. Ltd2,820$53K0.0%N/A0.003%
2/26/2026Seven Fleet Capital Management LP20,000$379K0.3%N/A0.019%
2/19/2026T. Rowe Price Investment Management Inc.172,838$3.28M0.0%-85.6%0.168%
2/19/2026 Invesco Ltd.343,830$6.52M0.0%+115.0%0.334%
2/18/2026XTX Topco Ltd11,520$219K0.0%-49.5%0.011%
2/18/2026Voloridge Investment Management LLC154,459$2.93M0.0%+3.6%0.150%
2/18/2026Vestal Point Capital LP4,690,000$88.97M3.0%+35.0%4.560%
2/18/2026Virtus Investment Advisers LLC13,949$265K0.1%+46.6%0.014%
2/18/2026Wellington Management Group LLP275,178$5.22M0.0%+7.6%0.268%
2/18/2026Susquehanna Portfolio Strategies LLC86,423$1.64M0.0%+476.1%0.084%
2/18/2026Tudor Investment Corp ET AL34,760$659K0.0%-8.4%0.034%
2/18/2026Sphera Funds Management LTD.124,000$2.35M0.4%N/A0.121%
2/18/2026Quadrature Capital Ltd10,172$193K0.0%N/A0.010%
2/18/2026Perceptive Advisors LLC3,555,877$67.46M1.2%+151.1%3.458%
2/18/2026Millennium Management LLC179,759$3.41M0.0%-88.2%0.175%
2/18/2026Janus Henderson Group PLC39,400$748K0.0%+50.4%0.038%
2/18/2026Elmind Capital LP460,000$8.73M2.6%N/A0.447%
2/18/2026Cinctive Capital Management LP47,707$905K0.0%-75.0%0.046%
2/18/2026Commodore Capital LP2,275,000$43.16M2.9%-39.8%2.212%
2/18/2026Balyasny Asset Management L.P.118,481$2.25M0.0%-2.6%0.115%
2/18/2026Baker BROS. Advisors LP4,658,556$88.37M0.5%+20.0%4.530%
2/17/2026Logos Global Management LP500,000$9.49M0.6%N/A0.486%
2/17/2026ADAR1 Capital Management LLC72,070$1.37M0.1%+131.0%0.070%
2/17/2026Burkehill Global Management LP118,972$2.26M0.1%N/A0.116%
2/17/2026Braidwell LP2,183,864$41.43M1.3%N/A2.124%
2/17/2026Trexquant Investment LP77,359$1.47M0.0%+419.2%0.075%
2/17/2026Jump Financial LLC80,037$1.52M0.0%N/A0.078%
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
2/17/2026Price T Rowe Associates Inc. MD3,248,361$61.62M0.0%+195.5%3.159%
2/17/2026T. Rowe Price Investment Management Inc.154,633$2.93M0.0%-87.1%0.150%
2/17/2026Integral Health Asset Management LLC300,000$5.69M0.3%-14.3%0.292%
2/17/2026Public Employees Retirement System of Ohio27,150$515K0.0%N/A0.026%
2/17/2026California State Teachers Retirement System68,019$1.29M0.0%+2.2%0.066%
2/17/2026General Atlantic L.P.4,897,159$92.90M3.2%N/A4.762%
2/17/2026 Russell Investments Group Ltd.63,482$1.20M0.0%+5.0%0.062%
2/17/2026State of Wisconsin Investment Board33,515$636K0.0%-15.7%0.033%
2/17/2026Royal Bank of Canada10,842$206K0.0%+17.6%0.011%
2/17/2026Opal Capital LLC12,078$229K0.1%N/A0.012%
2/16/2026Verition Fund Management LLC68,754$1.30M0.0%N/A0.067%
2/16/2026Mariner LLC28,004$531K0.0%N/A0.027%
2/16/2026Maven Securities LTD30,000$569K0.0%N/A0.029%
2/16/2026Kennedy Capital Management LLC261,204$4.96M0.1%+5.9%0.254%
2/16/2026Eventide Asset Management LLC1,297,893$24.62M0.4%N/A1.262%
2/16/2026Barclays PLC256,684$4.87M0.0%+4.7%0.250%
2/13/2026The Manufacturers Life Insurance Company 172,364$3.28M0.0%+579.9%0.168%
2/13/2026 Walleye Capital LLC74,869$1.42M0.0%N/A0.073%
2/13/2026Rubric Capital Management LP2,473,885$46.93M0.6%N/A2.406%
2/13/2026Hudson Bay Capital Management LP110,000$2.09M0.0%N/A0.107%
2/13/2026Morgan Stanley4,881,069$92.59M0.0%+115.9%4.746%
2/13/2026Jacobs Levy Equity Management Inc.735,174$13.95M0.1%+1,576.1%0.715%
2/13/2026Rafferty Asset Management LLC90,515$1.72M0.0%-2.1%0.088%
2/13/2026Charles Schwab Investment Management Inc.965,892$18.32M0.0%+11.7%0.939%
2/13/2026 Police & Firemen s Retirement System of New Jersey26,729$507K0.0%+27.8%0.026%
2/13/2026State Street Corp3,559,501$67.52M0.0%+24.4%3.461%
2/13/2026 Caitong International Asset Management Co. Ltd1,752$33K0.1%N/A0.002%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC168,843$3.20M0.0%+72.0%0.164%
2/13/2026 Wells Fargo & Company MN117,854$2.24M0.0%+94.1%0.115%
2/13/2026Rhenman & Partners Asset Management AB537,500$10.20M1.0%+54.7%0.523%
2/12/2026MetLife Investment Management LLC55,345$1.05M0.0%+22.4%0.054%
2/12/2026Intesa Sanpaolo Wealth Management1,610$31K0.0%N/A0.002%
2/12/2026 AlphaCentric Advisors LLC18,134$344K0.3%N/A0.018%
2/12/2026 IQ EQ FUND MANAGEMENT IRELAND Ltd65,545$1.24M0.1%+53.3%0.064%
2/12/2026 New York State Common Retirement Fund31,595$599K0.0%+49.1%0.031%
2/12/2026 Swiss National Bank150,000$2.85M0.0%+12.4%0.146%
2/12/2026 Nuveen LLC784,409$14.88M0.0%+415.9%0.763%
2/11/2026 ARK Investment Management LLC1,602,539$30.40M0.2%+6.1%1.558%
2/11/2026 Amova Asset Management Americas Inc.1,290,554$24.48M0.3%-17.1%1.255%
2/11/2026 Deutsche Bank AG2,486,792$47.17M0.0%+72.8%2.418%
2/10/2026 TD Asset Management Inc237,200$4.50M0.0%N/A0.231%
2/10/2026Goldman Sachs Group Inc.1,077,573$20.44M0.0%+73.2%1.048%
2/10/2026 Intech Investment Management LLC25,015$475K0.0%-24.8%0.024%
2/9/2026Geode Capital Management LLC2,384,998$45.25M0.0%+26.7%3.102%
2/6/2026 PSP Research LLC28,713$545K0.5%N/A0.037%
2/6/2026Larson Financial Group LLC1,541$29K0.0%+339.0%0.002%
2/6/2026 Handelsbanken Fonder AB547,000$10.38M0.0%+5.2%0.711%
2/6/2026 Profund Advisors LLC34,580$656K0.0%+69.1%0.045%
2/6/2026 ProShare Advisors LLC22,794$432K0.0%+46.0%0.030%
2/4/202649 Wealth Management LLC10,158$193K0.0%-13.0%0.013%
Peptide Company Lands Exclusive MMA Wellness Partnership (Ad)

A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.tc pixel

Read the full report on this small-cap peptide company now
1/29/2026 Pictet Asset Management Holding SA3,467,600$65.78M0.1%+75.1%4.510%
1/29/2026 UBS Group AG423,425$8.03M0.0%+16.8%0.551%
1/29/2026Vanguard Group Inc.5,949,512$112.86M0.0%+32.5%7.739%
1/29/2026 China Universal Asset Management Co. Ltd.16,518$313K0.0%+23.3%0.021%
1/28/2026 Arizona State Retirement System21,990$417K0.0%+8.2%0.029%
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank31,191$592K0.0%+65.7%0.041%
1/26/2026 Mirae Asset Global Investments Co. Ltd.4,926$93K0.0%+66.6%0.006%
1/23/2026 Sumitomo Mitsui Trust Group Inc.1,290,554$24.48M0.0%-17.1%1.679%
1/22/2026Massachusetts Financial Services Co. MA43,743$830K0.0%-6.1%0.057%
1/16/2026 Tema Etfs LLC76,625$1.45M0.1%+71.3%0.100%


NRIX Institutional Ownership - Frequently Asked Questions

During the previous two years, 210 institutional investors and hedge funds held shares of Nurix Therapeutics. The most heavily invested institutionals were FMR LLC ($200.35M), Vanguard Group Inc. ($112.86M), General Atlantic L.P. ($92.90M), Morgan Stanley ($92.59M), Vestal Point Capital LP ($88.97M), Baker BROS. Advisors LP ($88.37M), and State Street Corp ($67.52M).Learn more on Nurix Therapeutics' institutional investors.

Of the 187 institutional investors that purchased Nurix Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($10.56M), General Atlantic L.P. ($4.90M), Vestal Point Capital LP ($4.27M), Perceptive Advisors LLC ($2.94M), Morgan Stanley ($2.62M), Rubric Capital Management LP ($2.47M), and Braidwell LP ($2.18M).

Institutional investors have bought a total of 40,528,412 shares in the last 24 months. This purchase volume represents approximately $682.65M in transactions.

Of the 56 institutional investors that sold Nurix Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: T. Rowe Price Investment Management Inc. ($2.07M), Commodore Capital LP ($1.70M), Millennium Management LLC ($1.34M), UBS Group AG ($1.23M), Pictet Asset Management Holding SA ($741.46K), Driehaus Capital Management LLC ($563.75K), and Redmile Group LLC ($459.74K).

Institutional investors have sold a total of 11,514,778 shares in the last 24 months. This volume of shares sold represents approximately $174.14M in transactions.



This page (NASDAQ:NRIX) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners